Avalyn Pharma Inc. Common Stock
Status: Publicly traded
Direct answer
Avalyn Pharma Inc. Common Stock is publicly traded on NASDAQ under the ticker AVLN.
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate...
Can you invest in Avalyn Pharma Inc. Common Stock?
Yes. Avalyn Pharma Inc. Common Stock trades publicly on NASDAQ as AVLN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Avalyn Pharma Inc. Common Stock
Detailed equity research is provided by MarketSnap.